Shockwave Medical Acquires Neovasc

Quantum Surgical Acquires NeuWave Medical

February 27, 2026

Medical Devices

Quantum Surgical has acquired NeuWave Medical and combined both businesses under a newly created parent, Precision IO Group Inc., to expand a robotic-assisted tumor ablation platform. The deal is supported by investment from Ally Bridge Group and aims to integrate Quantum Surgical's Epione robotic system with NeuWave's microwave ablation technology to broaden access to minimally invasive interventional oncology care.

Philips Agrees to Acquire SpectraWAVE to Expand AI-Enabled Coronary Imaging and Physiology Portfolio

December 15, 2025

Medical Devices

Philips has agreed to acquire SpectraWAVE, a Bedford, Massachusetts-based developer of AI-enabled vascular imaging and coronary physiology assessment tools. The deal is intended to strengthen Philips’ image-guided therapy business by adding SpectraWAVE’s HyperVue Imaging System and X1-FFR software for intravascular imaging and angio-derived fractional flow reserve assessment.

Johnson & Johnson to Acquire V-Wave for Up to $1.7 Billion

October 9, 2024

Healthcare Services

Johnson & Johnson (J&J) entered into a definitive agreement to acquire V-Wave, a privately held heart-failure treatment company, for an upfront payment of $600 million and potential regulatory/commercial milestone payments up to about $1.1 billion (total up to ~$1.7 billion). The acquisition is expected to close before the end of 2024, and will add V-Wave’s Ventura Interatrial Shunt implant technology to the J&J MedTech Cardiovascular portfolio.

Johnson & Johnson to Acquire Shockwave Medical for $13.1 Billion

April 5, 2024

Healthcare Services

Johnson & Johnson (JNJ) entered into a definitive agreement to acquire all outstanding shares of Shockwave Medical for $335.00 per share in cash, implying an enterprise value of about $13.1 billion. The deal expands J&J MedTech’s cardiovascular intervention portfolio—adding Shockwave’s intravascular lithotripsy (IVL) technology for calcified coronary and peripheral artery disease.

Nevro Corp. Acquires Vyrsa Technologies

November 30, 2023

Medical Devices

Nevro Corp. acquired Vyrsa Technologies, a privately held medical technology company focused on minimally invasive sacroiliac (SI) joint fusion devices, in a deal that closed November 30, 2023. Nevro paid $40 million at closing and may pay up to an additional $35 million in cash or stock tied to development and sales milestones; the company said Vyrsa will broaden its product portfolio and is projected to be accretive in 2024.

Stryker Acquires Cerus Endovascular

May 2, 2023

Medical Devices

Stryker has completed the acquisition of Cerus Endovascular Ltd., a privately held, commercial-stage medical device company that developed the Contour Neurovascular System and Neqstent devices for treatment of intracranial aneurysms. The deal expands Stryker’s Neurovascular portfolio and strengthens its aneurysm/hemorrhagic treatment capabilities globally (reported purchase price approximately $530 million).